Skip to main content
Clinical Trials/NCT02210403
NCT02210403CompletedNot Applicable

The Influence of tDCS on the Arm and Hand Function in Stroke Patients

Universitaire Ziekenhuizen KU Leuven1 site in 1 country26 target enrollmentStarted: April 18, 2013Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
26
Locations
1
Primary Endpoint
Change of Fugl-Meyer assessment (FMA) score

Study Overview

Brief Summary

The purpose of this study is to determine whether tDCS in combination with motor training can improve hand and arm function in stroke patients.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Stroke patients onset > 6 months
  • •First ever stroke
  • •Decreased hand and arm function
  • •Mini Mental State Examination (>24)

Exclusion Criteria

  • •Depression
  • •Pregnancy
  • •Alcohol abuse
  • •Aneurysm clips
  • •Pacemaker
  • •Neurostimulator
  • •Implemented defibrillator
  • •Magnetically activated implant or device
  • •implemented pump
  • •Spinal cord simulator
  • •Implemented hearing aid
  • •Artificial or prosthetic limb
  • •Metal parts in the body
  • •Any external or internal metal
  • •Artificial heart valve
  • •Other implants
  • •History of brain surgery
  • •Family history of Epilepsy

Arms & Interventions

Upper limb motor function training + tDCS

Active Comparator

Bi-hemispheric tDCS with motor function training

Intervention: transcranial direct current stimulation (tDCS) (Device)

upper limb motor function training + sham tDCS

Sham Comparator

sham tDCS with motor function training

Intervention: transcranial direct current stimulation (tDCS) (Device)

Outcomes

Primary Outcomes

Change of Fugl-Meyer assessment (FMA) score

Time Frame: Change from baseline in FMA score on the 3rd intervention day; change from baseline in FMA score at 1 week post intervention

Secondary Outcomes

  • Change of Modified Ashworth scale (MAS)(Change from baseline in MAS scale on the 3rd intervention day; change from baseline in MAS scale at 1 week post intervention)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

The Influence of tDCS on the Arm and Hand... | Clinical Trial